Vivek Subbiah: Thanks to Ishwaria Subbiah for discussing this crucial topic with the US Social Security Administration.
Vivek Subbiah shared a post by Ishwaria Subbiah on LinkedIn, adding:
”Cancer is the 2nd leading cause of death among adults in the United States after heart disease. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA. Thanks to Ishwaria Subbiah, Sarah Cannon Research Institute, The US Oncology Network, The National Academies of Sciences, Engineering, and Medicine for discussing this crucial topic with the US Social Security Administration. Hoping for a huge real-world impact for cancer patients and survivors, as well as their caregivers! Cancer Awareness, Disability Benefits.”
Quoting Ishwaria Subbiah’s post:
”Thank you to The National Academies of Sciences, Engineering, and Medicine for the invitation to address the US Social Security Administration and the NASEM Standing Committee of Medical and Vocational Experts for the SSA’s Disability Programs. Our discussion on “New Developments in Diagnosing and Treating Adult Cancers” and the entire day of key sessions help shape the committee report which informs the SSA’s evaluation of disability claims for adults with cancer. Grateful to Sarah Cannon Research Institute, The US Oncology Network and the entire community of oncology professionals for ensuring that cutting edge cancer therapies go hand-in-hand with person-centered care! Read the most recent report below! Topics addressed include determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person’s health and functioning.”
For the article click here.
Source: Vivek Subbiah/LinkedIn
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute. He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center. Dr. Subbiah’s research interests include drug development in rare cancers, immunotherapy, and radiopharmaceuticals.
Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). In this role, Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US. Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023